Cargando…

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease

Parkinson’s disease (PD) is a complex and heterogeneous disorder involving multiple genetic and environmental influences. Although a wide range of PD risk factors and clinical markers for the symptomatic motor stage of the disease have been identified, there are still no reliable biomarkers availabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acharya, Shubhra, Salgado-Somoza, Antonio, Stefanizzi, Francesca Maria, Lumley, Andrew I., Zhang, Lu, Glaab, Enrico, May, Patrick, Devaux, Yvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555192/ https://www.ncbi.nlm.nih.gov/pubmed/32899928 http://dx.doi.org/10.3390/ijms21186513

Ejemplares similares

Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
por: Acharya, Shubhra, et al.
Publicado: (2021)

Non-Coding RNAs to Aid in Neurological Prognosis after Cardiac Arrest
por: Salgado-Somoza, Antonio, et al.
Publicado: (2018)

GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson’s Disease
por: Acharya, Shubhra, et al.
Publicado: (2023)

Approaching Sex Differences in Cardiovascular Non-Coding RNA Research
por: Jusic, Amela, et al.
Publicado: (2020)

Circulating Levels of Brain-Enriched MicroRNAs Correlate with Neuron Specific Enolase after Cardiac Arrest—A Substudy of the Target Temperature Management Trial †
por: Stefanizzi, Francesca Maria, et al.
Publicado: (2020)

RNAs in Brain and Heart Diseases †
por: Beis, Dimitris, et al.
Publicado: (2020)

Circular RNAs to predict clinical outcome after cardiac arrest
por: Stefanizzi, Francesca M., et al.
Publicado: (2022)

Correction: Circular RNAs to predict clinical outcome after cardiac arrest
por: Stefanizzi, Francesca M., et al.
Publicado: (2022)

Circular RNAs in the cardiovascular system
por: Gomes, Clarissa P.C., et al.
Publicado: (2018)

The circular RNA MICRA for risk stratification after myocardial infarction()
por: Salgado-Somoza, Antonio, et al.
Publicado: (2017)

Computational systems biology approaches for Parkinson’s disease
por: Glaab, Enrico
Publicado: (2017)

Identification of candidate long non-coding RNAs in response to myocardial infarction
por: Zangrando, Jennifer, et al.
Publicado: (2014)

Noncoding RNAs in Hypertension
por: Jusic, Amela, et al.
Publicado: (2019)

Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson’s Disease
por: Manna, Ida, et al.
Publicado: (2021)

Regulatory RNAs in Heart Failure
por: Gomes, Clarissa Pedrosa da Costa, et al.
Publicado: (2020)

The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease
por: Gomes, Clarissa P.C., et al.
Publicado: (2017)

Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease
por: Tranchevent, Léon-Charles, et al.
Publicado: (2023)

Comparative transcriptome analysis of Parkinson’s disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes
por: Hendrickx, Diana M., et al.
Publicado: (2020)

Whole transcriptome microarrays identify long non-coding RNAs associated with cardiac hypertrophy
por: Zhang, Lu, et al.
Publicado: (2015)

Body-First Subtype of Parkinson’s Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype
por: Pavelka, Lukas, et al.
Publicado: (2022)

Editorial: The Non-Coding Transcriptome as a New Player in Intercellular Communication
por: Devaux, Yvan, et al.
Publicado: (2022)

Editorial: Non-coding RNAs in heart failure
por: Booz, George W., et al.
Publicado: (2022)

Introduction: The Gut-Brain Axis in Parkinson’s Disease
por: van Laar, Teus
Publicado: (2019)

Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta‐analysis
por: Parvan, Reza, et al.
Publicado: (2022)

Circulating microRNAs and Outcome in Patients with Acute Heart Failure
por: Seronde, Marie-France, et al.
Publicado: (2015)

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
por: Lulli, Matteo, et al.
Publicado: (2022)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
por: Yang, Yimin, et al.
Publicado: (2021)

A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
por: Salemi, Michele, et al.
Publicado: (2022)

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
por: Zhang, Hanwen, et al.
Publicado: (2022)

Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure
por: Woudenberg, Tamar, et al.
Publicado: (2022)

Long non-coding RNAs in brain tumors
por: Katsushima, Keisuke, et al.
Publicado: (2021)

Long non-coding RNAs in the failing heart and vasculature
por: Hermans-Beijnsberger, Steffie, et al.
Publicado: (2018)

Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
por: Hobuß, Lisa, et al.
Publicado: (2019)

Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems
por: Spinetti, Gaia, et al.
Publicado: (2023)

Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation
por: Ohnmacht, Jochen, et al.
Publicado: (2020)

Heart-brain axis: Association of congenital heart abnormality and brain diseases
por: Sha, Leihao, et al.
Publicado: (2023)

Non-Coding RNAs and Cancer
por: Calore, Federica, et al.
Publicado: (2013)

Brain-heart axis - Review Article
por: Manea, MM, et al.
Publicado: (2015)

Microstates of the cortical brain‐heart axis
por: Catrambone, Vincenzo, et al.
Publicado: (2023)

Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
por: Pavelka, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4hp78un4uo5d2rc8uapqei81gh